Why Moderna Stock Rose Today

1 min read

Shares of Moderna (NASDAQ: MRNA) climbed 4% on Monday after the biotechnology company announced three new vaccine development programs. 

Moderna intends to use the lessons it learned with its coronavirus vaccine to advance its pipeline of drugs. The biotech will use its messenger RNA (mRNA) technology to develop vaccine candidates for the seasonal flu, human immunodeficiency virus (HIV), and Nipah virus. 

Moderna wants to broaden its vaccine portfolio. Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Ford Ending Production in Brazil; Will Book Roughly $4.1 Billion in Restructuring Charges

Next Story

Simulations Plus Inc (SLP) Q1 2021 Earnings Call Transcript

Latest from Blog